TIMP1 and neoplasm: Analysis of prostate adenocarcinoma samples from the GEPIA and UALCAN databases revealed significantly lower TIMP1 mRNA expression in tumor tissues compared with adjacent normal tissues (p < 0.001) (Fig. 1, A and B).